ウェアラブルパッチの世界市場予測(~2027年)

• 英文タイトル:Wearable Patch Market Research Report by Product, Technology, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Wearable Patch Market Research Report by Product, Technology, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「ウェアラブルパッチの世界市場予測(~2027年)」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301A182
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、229ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iリサーチ社の本レポートでは、2021年9,187.12百万ドルであったウェアラブルパッチの世界市場規模が、2022年には10,471.47百万ドルになり、その後CAGR 14.23%で増加して2027年までに20,416.14百万ドルに達すると予測しています。本書は、世界のウェアラブルパッチ市場を調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別(血糖パッチ、血中酸素パッチ、血圧パッチ、心電図パッチ、心拍パッチ)分析、技術別(コネクテッド、標準)分析、用途別(臨床、非臨床)分析、エンドユーザー別(フィットネス&スポーツ、医療)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報など、以下の項目を掲載しています。また、本書には、Abbott Laboratories、AliveCor, Inc.、Cardiac Insight Inc.、DarioHealth Corp.、Dexcom, Inc.、Gentag, Inc、Hill-Rom Holdings, Inc.、HIVOX BIOTEK INC.、Insulet Corporation、iRhythm Technologies, Inc.、Kenzen、Koninklijke Philips N.V.、L'Oréal S.A.などの企業情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界のウェアラブルパッチ市場規模:製品別
- 血糖パッチの市場規模
- 血中酸素パッチの市場規模
- 血圧パッチの市場規模
- 心電図パッチの市場規模
- 心拍パッチの市場規模
・世界のウェアラブルパッチ市場規模:技術別
- コネクテッドウェアラブルパッチの市場規模
- 標準ウェアラブルパッチの市場規模
・世界のウェアラブルパッチ市場規模:用途別
- 臨床における市場規模
- 非臨床における市場規模
・世界のウェアラブルパッチ市場規模:エンドユーザー別
- フィットネス&スポーツにおける市場規模
- 医療における市場規模
・世界のウェアラブルパッチ市場規模:地域別
- 南北アメリカのウェアラブルパッチ市場規模
アメリカのウェアラブルパッチ市場規模
カナダのウェアラブルパッチ市場規模
ブラジルのウェアラブルパッチ市場規模
...
- アジア太平洋のウェアラブルパッチ市場規模
日本のウェアラブルパッチ市場規模
中国のウェアラブルパッチ市場規模
インドのウェアラブルパッチ市場規模
韓国のウェアラブルパッチ市場規模
台湾のウェアラブルパッチ市場規模
...
- ヨーロッパ/中東/アフリカのウェアラブルパッチ市場規模
イギリスのウェアラブルパッチ市場規模
ドイツのウェアラブルパッチ市場規模
フランスのウェアラブルパッチ市場規模
ロシアのウェアラブルパッチ市場規模
...
- その他地域のウェアラブルパッチ市場規模
・競争状況
・企業情報

The Global Wearable Patch Market size was estimated at USD 9,187.12 million in 2021 and expected to reach USD 10,471.47 million in 2022, and is projected to grow at a CAGR 14.23% to reach USD 20,416.14 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Wearable Patch to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Blood Glucose Patch, Blood Oxygen Patch, Blood Pressure Patch, ECG Patch, Heart Rate Patch, and Temperature Patch.

Based on Technology, the market was studied across Connected and Regular.

Based on Application, the market was studied across Clinical and Non-clinical.

Based on End User, the market was studied across Fitness & Sports and Healthcare.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Wearable Patch market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Wearable Patch Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Wearable Patch Market, including Abbott Laboratories, AliveCor, Inc., Cardiac Insight Inc., DarioHealth Corp., Dexcom, Inc., Gentag, Inc, Hill-Rom Holdings, Inc., HIVOX BIOTEK INC., Insulet Corporation, iRhythm Technologies, Inc., Kenzen, Koninklijke Philips N.V., L’Oréal S.A., Leaf Healthcare, Inc, LifeSignals, Inc, Medtronic PLC, Nemaura Medical, Prevent Biometrics, Inc., Proteus Digital Health, Inc, Qualcomm Technologies, Inc, Sensium Healthcare Ltd, Texas Instruments Incorporated, VitalConnect, and Vivalnk, Inc.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Wearable Patch Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wearable Patch Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wearable Patch Market?
4. What is the competitive strategic window for opportunities in the Global Wearable Patch Market?
5. What are the technology trends and regulatory frameworks in the Global Wearable Patch Market?
6. What is the market share of the leading vendors in the Global Wearable Patch Market?
7. What modes and strategic moves are considered suitable for entering the Global Wearable Patch Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of chronic diseases such as diabetes & atrial fibrillation
5.1.1.2. Growing R&D investment for development of wearable patches
5.1.1.3. Demand for sensor patches to monitor glucose level
5.1.2. Restraints
5.1.2.1. Regulatory and compliance issues
5.1.3. Opportunities
5.1.3.1. Improve wearable patch features with technological advancements
5.1.3.2. Increasing telehealth adoption across the globe
5.1.4. Challenges
5.1.4.1. Risk of data security with connected devices
5.2. Cumulative Impact of COVID-19

6. Wearable Patch Market, by Product
6.1. Introduction
6.2. Blood Glucose Patch
6.3. Blood Oxygen Patch
6.4. Blood Pressure Patch
6.5. ECG Patch
6.6. Heart Rate Patch
6.7. Temperature Patch

7. Wearable Patch Market, by Technology
7.1. Introduction
7.2. Connected
7.3. Regular

8. Wearable Patch Market, by Application
8.1. Introduction
8.2. Clinical
8.3. Non-clinical

9. Wearable Patch Market, by End User
9.1. Introduction
9.2. Fitness & Sports
9.3. Healthcare

10. Americas Wearable Patch Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Wearable Patch Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Wearable Patch Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. AliveCor, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Cardiac Insight Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. DarioHealth Corp.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Dexcom, Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Gentag, Inc
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Hill-Rom Holdings, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. HIVOX BIOTEK INC.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Insulet Corporation
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. iRhythm Technologies, Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Kenzen
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Koninklijke Philips N.V.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. L’Oréal S.A.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Leaf Healthcare, Inc
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. LifeSignals, Inc
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Medtronic PLC
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Nemaura Medical
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Prevent Biometrics, Inc.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Proteus Digital Health, Inc
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Qualcomm Technologies, Inc
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Sensium Healthcare Ltd
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Texas Instruments Incorporated
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. VitalConnect
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Vivalnk, Inc
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing




• 英文レポート名:Wearable Patch Market Research Report by Product, Technology, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
• 日本語訳:ウェアラブルパッチの世界市場予測(~2027年)
• レポートコード:MRC2301A182お問い合わせ(見積依頼・ご注文・質問)